Drug intelligence / Profile preview

Hyalogy

Development stage
Unknown
Lead developer
Forlle'd
Modality
Nanoparticles → Drug Delivery Systems
Administration
Topical, Oral
01

Overview

Hyalogy is a line of advanced cosmeceutical products developed by the Japanese company Forlle'd, centered on a patented low-molecular-weight hyaluronic acid (LMWHA). Utilizing a proprietary fermentation and ionization process, the hyaluronic acid molecules are reduced to a size of 5 to 11 nanometers, which is significantly smaller than the 3,000+ nanometers of standard hyaluronic acid. This nanotechnology allows the molecules to cross the skin barrier and reach the dermal layers without the need for invasive injections. Once in the dermis, the LMWHA interacts with CD44 receptors to stimulate fibroblast activity, promoting the synthesis of endogenous collagen and elastin while providing intense hydration and antioxidant protection. The product line is primarily used for skin rejuvenation, anti-aging, and improving skin barrier function.

Brand names
HyalogyForlle'd Hyalogy
Other names
Low-molecular-weight hyaluronic acidP-effect
02

Targets

CD44 (CD44 antigen)HMMR

Beyond the preview

Go deeper on Hyalogy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyalogy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call